A comparative study of complications of vivax and falciparum malaria in Dehradun, India

S. P. Singh, Ragini Singh, Niaz Ahmad


Background: Traditionally Plasmodium falciparum has been considered to cause severe malaria while Plasmodium vivax is known to cause benign malaria. However many recent studies have shown that Plasmodium vivax is also responsible for many cases of severe malaria. There is scarcity of data on this topic from this region. The present study was conducted to find out clinical and pathological manifestations of vivax and falciparum malaria in Dehradun.

Methods: The study period was of one and half years, from January 2012 to June 2013. Patients of 18 years of age or above it who were smear positive or antigen positive were included in the study.

Results: one hundredand thirty nine patients were found to be suffering from malaria. 90 (64.7%) had vivax malaria, while 49 (35.3%) patients suffered from falciparum. The study of morbidity profile showed that the complications related to severity, earlier attributed to only falciparum is equally seen in vivax case. Low platelet count was the commonest finding in both groups. Other complications seen in both groups were those of severe anemia, cerebral malaria, ARDS, renal failure, hepatitis, leucocytopenia, pancytopenia, and shock. Mortality in the two groups was of the same order.

Conclusions: Vivax malaria causes significant mortality and morbidity. The morbidity and patterns are almost similar in both vivax and falciparum malaria.



Vivax malaria, Falciparum malaria, Dehradun

Full Text:



World Health Organization, World Malaria Report fact sheet. 2012. Available at: http://www.who.int Accessed 5 August 2013.

Basu S, Gupta P. Malaria. In: Ghai OP, Gupta P, editors. Text book of Social and Preventive Medicine. 3rd ed. New Delhi: CBS Publisher and distributors; 2010: 214-230.

Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Current Opin Infect Dis. 2009 Oct;22(5):430-5.

Li J et al. Geographic Subdivision of the Range of the Malaria Parasite, Plasmodium vivax. Emerging Infectious Diseases, Centers for Disease Control and Prevention. 2001 Jan-feb;7(1):35-42.

Severe falciparum malaria. World Health Organization, Communicable disease clusture. Trans R Soc Trop Med Hyg. 2000;94:S1-90.

World Health Organization, Regional Office of South East Region. Health topics: Malaria: World Malaria Report 2011. Available at: http://www.who. int Accessed 22 December 2012.

Nadkar MY, Huche AM, Singh Raminder, Pazare AR. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai. J Assoc physians India. 2012 October;6:11-3.

Mohapatra MK, Padhiary KN, Mishra DP, Sethy G. Atypical manifestations of plasmodium vivax malaria. Indian J Malariol. 2002;6:263-5.

Islam N, Qamruddin K. Unusual complicated in benign tertian malaria. Trop Geogr Med. 1995;47:141-3.

Mahgoub H, Gasim GI, Musa IR, Adam I. Severe Plasmosium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan. Parasites and Vectors. 2012, 5:154.

Shaikh S, Memon H, Iohamo B, Shaikh A, Ahmed I, Baird S. Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in South eastern Pakistan. Malarial Journal. 2012;11:144.

Jat KR, Guglani V, Khairwa Anju. Severe and complicated Plasmodium vivax malaria in children. Trop Doct. 2012 Oct;42:185-7.

Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in north-western India. Am J Trop Med Hyg. 2009;80:194-8.

Antinori S, Galimberti L, Erika G, Paola M, Anna R, Veronica A. Thrombocytopenia and Plasmodium vivax malaria. Clin Infect Dis. 2005;41(8):1210-2.

Makkar RP, Monga SM, Gupta AK. Plasmodium vivax malaria presenting with severe thrombocytopenia. Braz J Infect Dis. 2002;47:24-6.

Sharma A and Khanduri U. How benign is benign tertian malaria? J Vector Dis. June 2009;46:141-2.

Narang GS and Singh N. Thrombocytopenia and other complications of Plasmodium vivax malaria. Curr Pediatric Res. 2011;15 (2):117-9.

Yamaguchi S, Kubota T, Yamagishi T et al. Severe thrombocytopenia suggesting immunological mechanism in two cases of vivax malaria. Am J Hematol. 1997;56(3):183-6.

Fajarda LF, Tallent C. Malaria parasites within human platelets. JAMA. 1974;229:1205.

Rodriguez MAJ, Sanchez E, Varges M, Piccolo C, Colina R, Arria M et al. Occurrence of Thrombocytopenia in plasmodium vivax malaria. Clin Infect dis. 2005;4:130-1.

Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ et al. The anemia of Plasmodium vivex malaria. Malar J. 2012;11:135.

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000;94:S1-90.

Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, Gupta A et al. Clinical features of children hospitalized with malaria - a study from Bikaner, Northwest India. Am J Trop Med Hyg. 2010;83(5):981-9.

Torres JR, Perez H, Postigo MM, Silva JR. Acute non cardiogenic lung injury in benign tertian malaria. Lancet. 1997;350:31-2.

Anstey NM; Handojo T, Pain MC, Kenangalem E, Tjitra E et al. Lung injury in vivax malaria: Patho physiological evidence for pulmonary vascular sequestration and post treatment alveolar - capillary inflammation. J Infect Dis. 2007;195:589-96.

Anstey NM, Jacups SP, Cain T, Pearson T, Zeising PJ, Fisher DA et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough small airway obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis. 2002;185:1326-34.